As of 2025-11-26, the Relative Valuation of Regeneron Pharmaceuticals Inc (REGN) is 714.16 USD. This relative valuation is based on P/E multiples. With the latest stock price at 787.32 USD, the upside of Regeneron Pharmaceuticals Inc based on Relative Valuation is -9.3%.
The range of the Relative Valuation is 615.93 - 1,133.72 USD.
| Range | Selected | |
| Trailing P/E multiples | 14.3x - 17.3x | 15.8x |
| Forward P/E multiples | 16.3x - 26.6x | 17.5x |
| Fair Price | 615.93 - 1,133.72 | 714.16 |
| Upside | -21.8% - 44.0% | -9.3% |
| Date | P/E |
| 2025-11-25 | 18.23 |
| 2025-11-24 | 17.63 |
| 2025-11-21 | 17.50 |
| 2025-11-20 | 17.06 |
| 2025-11-19 | 16.27 |
| 2025-11-18 | 16.79 |
| 2025-11-17 | 16.31 |
| 2025-11-14 | 16.06 |
| 2025-11-13 | 16.09 |
| 2025-11-12 | 15.78 |
| 2025-11-11 | 15.62 |
| 2025-11-10 | 15.16 |
| 2025-11-07 | 15.22 |
| 2025-11-06 | 14.98 |
| 2025-11-05 | 14.91 |
| 2025-11-04 | 14.54 |
| 2025-11-03 | 14.87 |
| 2025-10-31 | 15.09 |
| 2025-10-30 | 15.14 |
| 2025-10-29 | 15.12 |
| 2025-10-28 | 15.15 |
| 2025-10-27 | 13.55 |
| 2025-10-24 | 13.38 |
| 2025-10-23 | 13.33 |
| 2025-10-22 | 13.54 |
| 2025-10-21 | 13.41 |
| 2025-10-20 | 13.35 |
| 2025-10-17 | 13.38 |
| 2025-10-16 | 13.18 |
| 2025-10-15 | 13.35 |
| 2025-10-14 | 13.26 |
| 2025-10-13 | 12.91 |
| 2025-10-10 | 13.07 |
| 2025-10-09 | 13.19 |
| 2025-10-08 | 13.05 |
| 2025-10-07 | 13.50 |
| 2025-10-06 | 13.56 |
| 2025-10-03 | 13.89 |
| 2025-10-02 | 13.89 |
| 2025-10-01 | 13.89 |
| 2025-09-30 | 13.02 |
| 2025-09-29 | 12.98 |
| 2025-09-26 | 13.06 |
| 2025-09-25 | 12.86 |
| 2025-09-24 | 13.36 |
| 2025-09-23 | 13.15 |
| 2025-09-22 | 13.79 |
| 2025-09-19 | 13.71 |
| 2025-09-18 | 13.86 |
| 2025-09-17 | 13.56 |